Taylor Ben R sold RXRX
February 18, 2026 · Form 4 insider transaction
Taylor Ben R sold 13,426 shares of Recursion Pharmaceuticals, Inc. at $3.08 per share, a transaction worth $41.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
13,426
Price
$3.08
Total value
$41.4K
InsiderTaylor Ben R
Role—
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 18, 2026
Filing dateFebruary 19, 2026
Shares owned after1,195,349
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025.